Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina

Cardiovascular Drugs and Therapy
T E MeyerP Commerford

Abstract

There is still uncertainty of whether combined therapy with a beta-blocker and calcium-channel antagonist provides additive or synergistic clinical benefits in most patients with stable angina pectoris. The comparative antianginal effect of atenolol 50 mg and atenolol 50 mg and slow release nifedipine (20 mg) twice a day was assessed in 27 patients with chronic stable angina in a randomized, double-blind, crossover study. After a 4 week run-in period on atenolol, patients were randomly allocated to receive either atenolol alone or its combination with nifedipine and then crossed over to the alternative treatment for a further 4 weeks. Symptom-limited exercise treadmill tests were performed according to the Naughton protocol. The major endpoints in this study were (a) exercise time to pain; (b) exercise time to > or = 1 mm ST depression; (c) total exercise time; (d) maximal ST-segment depression; (e) number of anginal attacks; and (f) nitrate consumption. The preexercise systolic blood pressure was lower on the combination treatment than on atenolol alone, but heart rate was lower on atenolol compared with the combination treatment. There was no difference in the systolic blood pressure at the onset of pain or at 1 mm ST depress...Continue Reading

References

Oct 22, 1979·The American Journal of Cardiology·F A Heupler, W L Proudfit
Dec 1, 1990·Circulation·A Maseri
Mar 16, 1989·The New England Journal of Medicine·M Packer
Jul 15, 1989·The American Journal of Cardiology·W ShapiroL R Zohman
Apr 1, 1986·The American Journal of Cardiology·A UusitaloH Wendelin
Sep 18, 1985·The American Journal of Cardiology·A MaseriJ C Kaski
Jan 1, 1982·The American Journal of Cardiology·B SubramanianE B Raftery

❮ Previous
Next ❯

Citations

May 20, 1998·The American Journal of Cardiology·P H DunselmanP J Bernink
Jul 15, 2005·The American Journal of Geriatric Cardiology·Gary E Sander, Thomas D Giles
Jan 31, 2020·Current Cardiology Reports·Jose B Cruz Rodriguez, Haider Alkhateeb
Jan 23, 2020·Current Cardiology Reports·Jose B Cruz Rodriguez, Subrata Kar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.